CH Term (R4)
3.5.0-ci-build - ci-build
CH Term (R4)
3.5.0-ci-build - ci-build
CH Term (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.5.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-term/ and changes regularly. See the Directory of published versions
| Official URL: http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm | Version: 3.5.0-ci-build | |||
| Active as of 2026-07-08 | Computable Name: ImmunGlobulineToTargetDiseaseMapping | |||
Copyright/Legal: This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org. |
||||
Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets
Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to CH VACD Target disease and illnesses undergone for immunization
Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to SNOMED CT (all versions)
| Source Concept Details | Relationship | Target Concept Details | ||
| Codes from CH VACD Swissmedic Authorized Immunoglobulin Codes | Codes from SNOMED CT (all versions) | |||
| 00687-01 | Berirab 2 ml, Injektionslösung | is related to | 14168008 | Rabies (disorder) |
| 00687-02 | Berirab 5 ml, Injektionslösung | is related to | 14168008 | Rabies (disorder) |
| 69039-02 | Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 69039-01 | Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 68222-01 | Cutaquig 165 mg/ml, Injektionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 65992-01 | Cuvitru 200 mg/ml, Injektionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 00506-02 | Cytotect CP Biotest, Infusionslösung | is related to | 28944009 | Infection caused by Cytomegalovirus (disorder) |
| 00701-02 | Gammanorm, Injektionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 16318001000119107 | Hypogammaglobulinemia due to multiple myeloma (disorder) | ||
| 00668-01 | Gamunex 10%, solution pour injection intraveineuse | is related to | 14189004 | Measles (disorder) |
| 00488-02 | Hepatect CP, Infusionslösung | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 00674-01 | Hepatitis-B-Immunglobulin Behring, Injektionslösung | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 66410-01 | Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 61547-01 | Hizentra, Injektionslösung zur s.c. Anwendung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66684-01 | HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 58157-01 | Ig Vena Kedrion 50 g/I, solution pour infusion | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 62913-01 | Intratect 10%, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 57676-01 | Intratect 5%, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-03 | Iqymune 10g/100ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-04 | Iqymune 20g/200ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-01 | Iqymune 2g/20ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-02 | Iqymune 5g/50ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 57469-01 | Kiovig, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 60323-01 | Octagam 10 %, Lösung zur intravenösen Anwendung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 58314-01 | Privigen, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 53609-02 | Rhophylac 300, Injektionslösung | is related to | 165746003 | RhD negative (finding) |
| 65695-02 | Synagis 100 mg/1 ml, Injektionslösung | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 65695-01 | Synagis 50 mg/0.5 ml, Injektionslösung | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 00673-02 | Tetagam P, Injektionslösung | is related to | 76902006 | Tetanus (disorder) |
| 59374-01 | Uman Big 180 UI/1 ml, solution pour injection intramusculaire | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 59374-02 | Uman Big 540 UI/3 ml, solution pour injection intramusculaire | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 59451-01 | Varitect CP, Lösung zur intravenösen Injektion | is related to | 38907003 | Varicella (disorder) |
| 59373-02 | Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 59373-01 | Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 68471-01 | Xevudy, Konzentrat zur Herstellung einer Infusionslösung | is related to | 840539006 | Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) |
| 66344-01 | Zinplava, Konzentrat zur Herstellung einer Infusionslösung | is related to | 56688005 | Clostridial infection (disorder) |
| 61639-01 | Zutectra, Injektionslösung | is related to | 66071002 | Viral hepatitis type B (disorder) |